These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36355620)
1. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma. Kadariya Y; Sementino E; Shrestha U; Gorman G; White JM; Ross EA; Clapper ML; Neamati N; Miller MS; Testa JR Carcinogenesis; 2022 Dec; 43(12):1137-1148. PubMed ID: 36355620 [TBL] [Abstract][Full Text] [Related]
2. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer. Xu S; Grande F; Garofalo A; Neamati N Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726 [TBL] [Abstract][Full Text] [Related]
4. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. Pozios I; Hering NA; Guenzler E; Arndt M; Elezkurtaj S; Knösel T; Bruns CJ; Margonis GA; Beyer K; Seeliger H J Cancer Res Clin Oncol; 2023 Jan; 149(1):271-280. PubMed ID: 36495330 [TBL] [Abstract][Full Text] [Related]
5. The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium. Benvenuto M; Mattera R; Taffera G; Giganti MG; Lido P; Masuelli L; Modesti A; Bei R Nutrients; 2016 May; 8(5):. PubMed ID: 27171110 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Prevents Asbestos-Induced Inflammation and Genotoxic Cell Damage in Human Mesothelial Cells. Pietrofesa RA; Chatterjee S; Kadariya Y; Testa JR; Albelda SM; Christofidou-Solomidou M Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077483 [TBL] [Abstract][Full Text] [Related]
7. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf). Chernova T; Murphy FA; Galavotti S; Sun XM; Powley IR; Grosso S; Schinwald A; Zacarias-Cabeza J; Dudek KM; Dinsdale D; Le Quesne J; Bennett J; Nakas A; Greaves P; Poland CA; Donaldson K; Bushell M; Willis AE; MacFarlane M Curr Biol; 2017 Nov; 27(21):3302-3314.e6. PubMed ID: 29112861 [TBL] [Abstract][Full Text] [Related]
8. Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort. Robinson C; Alfonso H; Woo S; Olsen N; Bill Musk AW; Robinson BW; Nowak AK; Lake RA Lung Cancer; 2014 Oct; 86(1):29-34. PubMed ID: 25175318 [TBL] [Abstract][Full Text] [Related]
9. A mouse model recapitulating molecular features of human mesothelioma. Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281 [TBL] [Abstract][Full Text] [Related]
10. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure. Dragon J; Thompson J; MacPherson M; Shukla A J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056 [TBL] [Abstract][Full Text] [Related]
11. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma. Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199 [TBL] [Abstract][Full Text] [Related]
12. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production. Chew SH; Okazaki Y; Nagai H; Misawa N; Akatsuka S; Yamashita K; Jiang L; Yamashita Y; Noguchi M; Hosoda K; Sekido Y; Takahashi T; Toyokuni S Carcinogenesis; 2014 Jan; 35(1):164-72. PubMed ID: 23917077 [TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma. Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549 [TBL] [Abstract][Full Text] [Related]
14. Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma. Testa JR; Kadariya Y; Friedberg JS Oncoscience; 2024; 11():53-57. PubMed ID: 38784478 [TBL] [Abstract][Full Text] [Related]
15. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Carbone M; Yang H Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079 [TBL] [Abstract][Full Text] [Related]
16. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530 [TBL] [Abstract][Full Text] [Related]
17. Activating the interleukin-6-Gp130-STAT3 pathway ameliorates ventricular electrical stability in myocardial infarction rats by modulating neurotransmitters in the paraventricular nucleus. Gao M; Yin D; Chen J; Qu X BMC Cardiovasc Disord; 2020 Feb; 20(1):60. PubMed ID: 32024466 [TBL] [Abstract][Full Text] [Related]
18. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review. Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108 [TBL] [Abstract][Full Text] [Related]
19. Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Hillegass JM; Miller JM; MacPherson MB; Westbom CM; Sayan M; Thompson JK; Macura SL; Perkins TN; Beuschel SL; Alexeeva V; Pass HI; Steele C; Mossman BT; Shukla A Part Fibre Toxicol; 2013 Aug; 10():39. PubMed ID: 23937860 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]